183 related articles for article (PubMed ID: 12074702)
1. The effects of capsaicin topical therapy in dogs with atopic dermatitis: a randomized, double-blinded, placebo-controlled, cross-over clinical trial.
Marsella R; Nicklin CF; Melloy C
Vet Dermatol; 2002 Jun; 13(3):131-9. PubMed ID: 12074702
[TBL] [Abstract][Full Text] [Related]
2. Investigation on the clinical efficacy and safety of 0.1% tacrolimus ointment (Protopic) in canine atopic dermatitis: a randomized, double-blinded, placebo-controlled, cross-over study.
Marsella R; Nicklin CF; Saglio S; Lopez J
Vet Dermatol; 2004 Oct; 15(5):294-303. PubMed ID: 15500481
[TBL] [Abstract][Full Text] [Related]
3. Pilot evaluation of the antipruritic efficacy of a topical transient receptor potential melastatin subfamily 8 (TRPM8) agonist in dogs with atopic dermatitis and pedal pruritus.
Tamamoto-Mochizuki C; Murphy KM; Olivry T
Vet Dermatol; 2018 Feb; 29(1):29-e14. PubMed ID: 28952176
[TBL] [Abstract][Full Text] [Related]
4. Barazone decreases skin lesions and pruritus and increases quality of life in dogs with atopic dermatitis: a randomized, blinded, placebo-controlled trial.
Ahlstrom LA; Mason KV; Mills PC
J Vet Pharmacol Ther; 2010 Dec; 33(6):573-82. PubMed ID: 21062310
[TBL] [Abstract][Full Text] [Related]
5. Cyclosporine decreases skin lesions and pruritus in dogs with atopic dermatitis: a blinded randomized prednisolone-controlled trial.
Olivry T; Rivierre C; Jackson HA; Murphy KM; Davidson G; Sousa CA
Vet Dermatol; 2002 Apr; 13(2):77-87. PubMed ID: 11972891
[TBL] [Abstract][Full Text] [Related]
6. Tepoxalin reduces pruritus and modified CADESI-01 scores in dogs with atopic dermatitis: a prospective, randomized, double-blinded, placebo-controlled, cross-over study.
Horvath-Ungerboeck C; Thoday KL; Shaw DJ; van den Broek AH
Vet Dermatol; 2009 Aug; 20(4):233-42. PubMed ID: 19552701
[TBL] [Abstract][Full Text] [Related]
7. A randomized, double-blind, placebo-controlled study to evaluate the effect of EFF1001, an Actinidia arguta (hardy kiwi) preparation, on CADESI score and pruritus in dogs with mild to moderate atopic dermatitis.
Marsella R; Messinger L; Zabel S; Rosychuck R; Griffin C; Cronin PO; Belofsky G; Lindemann J; Stull D
Vet Dermatol; 2010 Feb; 21(1):50-7. PubMed ID: 19843302
[TBL] [Abstract][Full Text] [Related]
8. Investigation on the use of 0.3% tacrolimus lotion for canine atopic dermatitis: a pilot study.
Marsella R; Nicklin CF
Vet Dermatol; 2002 Aug; 13(4):203-10. PubMed ID: 12174182
[TBL] [Abstract][Full Text] [Related]
9. Use of antipruritic and rehydrating foams on localized lesions of atopic dermatitis in dogs: a small-scale pilot and comparative double-blinded study.
Bensignor EJ; Fabriès LJ
Vet Dermatol; 2018 Oct; 29(5):446-e150. PubMed ID: 30079617
[TBL] [Abstract][Full Text] [Related]
10. Double blinded, vehicle controlled, crossover study on the efficacy of a topical endocannabinoid membrane transporter inhibitor in atopic Beagles.
Marsella R; Ahrens K; Sanford R; Trujillo A; Massre D; Soeberdt M; Abels C
Arch Dermatol Res; 2019 Dec; 311(10):795-800. PubMed ID: 31446453
[TBL] [Abstract][Full Text] [Related]
11. Randomized, double-blinded, placebo-controlled pilot study on the effects of topical blackcurrant emulsion enriched in essential fatty acids, ceramides and 18-beta glycyrrhetinic acid on clinical signs and skin barrier function in dogs with atopic dermatitis.
Marsella R; Cornegliani L; Ozmen I; Bohannon M; Ahrens K; Santoro D
Vet Dermatol; 2017 Dec; 28(6):577-e140. PubMed ID: 28736984
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of a 0.0584% hydrocortisone aceponate spray in the management of canine atopic dermatitis: a randomised, double blind, placebo-controlled trial.
Nuttall T; Mueller R; Bensignor E; Verde M; Noli C; Schmidt V; Rème C
Vet Dermatol; 2009 Jun; 20(3):191-8. PubMed ID: 19374721
[TBL] [Abstract][Full Text] [Related]
13. Randomized controlled trial of the efficacy of cyclosporine in the treatment of atopic dermatitis in dogs.
Olivry T; Steffan J; Fisch RD; Prélaud P; Guaguère E; Fontaine J; Carlotti DN;
J Am Vet Med Assoc; 2002 Aug; 221(3):370-7. PubMed ID: 12164533
[TBL] [Abstract][Full Text] [Related]
14. A blinded, randomized, placebo-controlled, dose determination trial of lokivetmab (ZTS-00103289), a caninized, anti-canine IL-31 monoclonal antibody in client owned dogs with atopic dermatitis.
Michels GM; Ramsey DS; Walsh KF; Martinon OM; Mahabir SP; Hoevers JD; Walters RR; Dunham SA
Vet Dermatol; 2016 Dec; 27(6):478-e129. PubMed ID: 27647569
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of a new topical cyclosporine A formulation in the treatment of atopic dermatitis in dogs.
Puigdemont A; Brazís P; Ordeix L; Dalmau A; Fuertes E; Olivar A; Pérez C; Ravera I
Vet J; 2013 Aug; 197(2):280-5. PubMed ID: 23562341
[TBL] [Abstract][Full Text] [Related]
16. A blinded, randomized clinical trial comparing the efficacy and safety of oclacitinib and ciclosporin for the control of atopic dermatitis in client-owned dogs.
Little PR; King VL; Davis KR; Cosgrove SB; Stegemann MR
Vet Dermatol; 2015 Feb; 26(1):23-30, e7-8. PubMed ID: 25496303
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of AHR-13268, an antiallergenic compound, in the management of pruritus caused by atopic disease in dogs.
DeBoer DJ; Moriello KA; Pollet RA
Am J Vet Res; 1992 Apr; 53(4):532-6. PubMed ID: 1350185
[TBL] [Abstract][Full Text] [Related]
18. Double-blinded, placebo-controlled study to evaluate an antipruritic shampoo for dogs with allergic pruritus.
Schilling J; Mueller RS
Vet Rec; 2012 Jul; 171(4):97. PubMed ID: 22678620
[TBL] [Abstract][Full Text] [Related]
19. The glucocorticoid sparing efficacy of Phytopica in the management of canine atopic dermatitis.
Schmidt V; McEwan N; Volk A; Helps J; Morrell K; Nuttall T
Vet Dermatol; 2010 Feb; 21(1):96-105. PubMed ID: 20187915
[TBL] [Abstract][Full Text] [Related]
20. The efficacy of a commercial shampoo and whirlpooling in the treatment of canine pruritus - a double-blinded, randomized, placebo-controlled study.
Löflath A; von Voigts-Rhetz A; Jaeger K; Schmid M; Kuechenhoff H; Mueller RS
Vet Dermatol; 2007 Dec; 18(6):427-31. PubMed ID: 17991160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
